The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity

Italian Journal of Anatomy and Embryology

Volumn 117, Issue 2, 2012, Pages 75-97

  Marmiroli, Paola ^a   Nicolini, Gabriella ^a   Miloso, Mariarosaria ^a   Scuteri, Arianna ^a   Cavaletti, Guido ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Chemotherapy; Dorsal root ganglia; Morphology; Neuropathy; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CULTURE TECHNIQUE; DISEASE MODEL; HUMAN; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; STANDARD; TOXICITY AND INTOXICATION; TOXICOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HUMANS; NEUROTOXICITY SYNDROMES; PERIPHERAL NERVOUS SYSTEM DISEASES; TOXICOLOGY;

EID: 84870851045     PISSN: 11226714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Apfel S.C. (2000) Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors. Cancer Invest. 18: 564-573. (Pubitemid 30485673)
2. Argyriou A.A., Polychronopoulos P., Iconomou G., Koutras A., Kalofonos H.P., Chroni E. (2005) Paclitaxel plus carboplatin-induced peripheral neuropathy. A prospective clinical and electrophysiological study in patients suffering from solid malignancies. J. Neurol. 252: 1459-1464. (Pubitemid 41803834)
3. Argyriou A.A., Polychronopoulos P., Koutras A., Xiros N., Petsas T., Argyriou K., Kalofonos H.P., Chroni E. (2007) Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy. Eur. J. Cancer Care 16: 231-237.
4. Argyriou A.A., Iconomou G., Kalofonos H.P. (2008) Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 112: 1593-1599.
5. Authier N., Coudore F., Eschalier A., Fialip J. (1999) Pain related behaviour during vincristine-induced neuropathy in rats. Neuroreport 10: 965-968. (Pubitemid 29317973)
6. Authier N., Gillet J.P., Fialip J., Eschalier A., Coudore F. (2003) A new animal model of vincristine-induced nociceptive peripheral neuropathy. Neurotoxicology 24: 797-805. (Pubitemid 37486255)
7. Barajon I., Bersani M., Quartu M., Del Fiacco M., Cavaletti G., Holst J.J., Tredici G. (1996) Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Exp. Neurol. 138: 93-104. (Pubitemid 26107992)
8. Bianchi R., Brines M., Lauria G., Savino C., Gilardini A., Nicolini G., Rodriguez-Menendez V., Oggioni N., Canta A., Penza P., Lombardi R., Minoia C., Ronchi A., Cerami A., Ghezzi P., Cavaletti G. (2006) Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. Clin. Cancer Res. 12: 2607-2612.
9. Bruna J., Udina E., Ale A., Vilches J.J., Vynckier A., Monbaliu J., Silverman L., Navarro X. (2010) Neurophysiological, histological and immunohistochemical characterization of bortezomib-induced neuropathy in mice. Exp. Neurol. 223: 599-608.
10. Canta A., Meregalli C., Chiorazzi A., Carozzi V.A., Crippa L., Marmiroli P., Cavaletti G. (2010) The ventral caudal nerve: a physiologic-morphometric study in three different rat strains. J. Peripher. Nerv. Syst. 15: 140-146.
11. Carozzi V.A., Canta A., Oggioni N., Sala B., Chiorazzi A., Meregalli C., Bossi M., Marmiroli P., Cavaletti G. (2010) Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies. Exp. Neurol. 226: 301-309.
12. Cavaletti G. (2008) Peripheral neurotoxicity of platinum-based chemotherapy. Nat. Rev. Cancer 8: 1p following 71.
13. Cavaletti G., Marmiroli P. (2004) Chemotherapy-induced peripheral neurotoxicity. Expert Opin. Drug Saf. 3: 535-546. (Pubitemid 39530207)
14. Cavaletti G., Marmiroli P. (2010) Chemotherapy-induced peripheral neurotoxicity. Nat. Rev. Neurol. 6: 657-666.
15. Cavaletti G., Nobile-Orazio E. (2007) Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Haematologica 92: 1308-1310. (Pubitemid 350144147)
16. Cavaletti G., Minoia C., Schieppati M., Tredici G. (1994) Protective effects of glutathione on cisplatin neurotoxicity in rats. Int. J. Radiat. Oncol. Biol. Phys. 29: 771-776. (Pubitemid 24241317)
17. Cavaletti G., Tredici G., Braga M., Tazzari S. (1995) Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp. Neurol. 133: 64-72.
18. Cavaletti G., Tredici G., Pizzini G., Minoia A. (1990) Tissue platinum concentrations and cisplatin schedules. Lancet 336: 1003. (Pubitemid 20349619)
19. Cavaletti G., Fabbrica D., Minoia C., Frattola L., Tredici G. (1998) Carboplatin toxic effects on the peripheral nervous system of the rat. Ann. Oncol. 9: 443-447. (Pubitemid 28273039)
20. Cavaletti G., Tredici G., Marmiroli P., Petruccioli M.G., Barajon I., Fabbrica D. (1992) Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats. Acta Neuropathol. (Berlin) 84: 364-371.
21. Cavaletti G., Cavalletti E., Montaguti P., Oggioni N., De Negri O., Tredici G. (1997) Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. Neurotoxicology 18: 137-145.
22. Cavaletti G., Cavalletti E., Oggioni N., Sottani C., Minoia C., D'Incalci M., Zucchetti M., Marmiroli P., Tredici G. (2000) Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration. Neurotoxicology 21: 389-393.
23. Cavaletti G., Pezzoni G., Pisano C., Oggioni N., Sala F., Zoia C., Ferrarese C., Marmiroli P., Tredici G. (2002b) Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor. Neurosci. Lett. 322: 103-106. (Pubitemid 34212031)
24. Cavaletti G., Tredici G., Petruccioli M.G., Dondè E., Tredici P., Marmiroli P., Minoia C., Ronchi A., Bayssas M., Etienne G.G. (2001) Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat. Eur. J. Cancer 37: 2457-2463. (Pubitemid 33097486)
25. Cavaletti G., Gilardini A., Canta A., Rigamonti L., Rodriguez-Menendez V., Ceresa C., Marmiroli P., Bossi M., Oggioni N., D'Incalci M., De Coster R. (2007b) Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. Exp. Neurol. 204: 317-325 (Pubitemid 46330280)
26. Cavaletti G., Petruccioli M.G., Marmiroli P., Rigolio R., Galbiati S., Zoia C., Ferrarese C., Tagliabue E., Dolci C., Bayssas M., Griffon Etienne G., Tredici G. (2002a) Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat. Anticancer Res. 22: 4199-4204. (Pubitemid 36134457)
27. Cavaletti G., Bogliun G., Marzorati L., Zincone A., Piatti M., Colombo N., Franchi D., La Presa M.T., Lissoni A., Buda A., Fei F., Cundari S., Zanna C. (2004) Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. Ann. Oncol. 15: 1439-1442. (Pubitemid 39295034)
28. Cavaletti G., Frigeni B., Lanzani F., Piatti M., Rota S., Briani C., Zara G., Plasmati R., Pastorelli F., Caraceni A., Pace A., Manicone M., Lissoni A., Colombo N., Bianchi G., Zanna C. (2007a) The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J. Peripher. Nerv. Syst. 12: 210-215. (Pubitemid 47404378)
29. Chaudhry V., Cornblath D.R., Polydefkis M., Ferguson A., Borrello I. (2008) Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy. J. Peripher. Nerv. Syst. 13: 275-282.
30. Chiorazzi A., Nicolini G., Canta A., Oggioni N., Rigolio R., Cossa G., Lombardi R., Roglio I., Cervellini I., Lauria G., Melcangi R.C., Bianchi R., Crippa D., Cavaletti G. (2009) Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies. Neurobiol. Dis. 35: 270-277.
31. Fischer S.J., McDonald E.S., Gross L., Windebank A.J. (2001) Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo. Neurobiol. Dis. 8: 1027-1035. (Pubitemid 34017096)
32. Flatters S.J., Bennett G.J. (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain 122: 245-257. (Pubitemid 43729476)
33. Ghirardi O., Vertechy M., Vesci L., Canta A., Nicolini G., Galbiati S., Ciogli C., Quattrini G., Pisano C., Cundari S., Rigamonti L.M. (2005) Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine. In Vivo 19: 631-637.
34. Gregg R.W., Molepo J.M., Monpetit V.J., Mikael N.Z., Redmond D., Gadia M., Stewart D.J. (1992) Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J. Clin. Oncol. 10: 795-803.
35. Higuera E.S., Luo Z.D. (2004) A rat pain model of vincristine-induced neuropathy. Methods Mol. Med. 99: 91-98.
36. Himes R.H., Kersey R.N., Heller-Bettinger I., Samson F.E. (1976) Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res. 36: 3798-3802.
37. Inbar M., Merimsky O., Wigler N., Chaitchik S. (1992) Cisplatin-related Lhermitte's sign. Anticancer Drugs 3: 375-377.
38. Jin H.W., Flatters S.J., Xiao W.H., Mulhern H.L., Bennett G.J. (2008) Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-l-carnitine: Effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp. Neurol. 210: 229-237.
39. Lanzani F., Mattavelli L., Frigeni B., Rossini F., Cammarota S., Petrò D., Jann S., Cavaletti G. (2008) Role of a pre-existing neuropathy on the course of bortezomibinduced peripheral neurotoxicity. J. Peripher. Nerv. Syst. 13: 267-274.
40. Lauria G., Lombardi R., Borgna M., Penza P., Bianchi R., Savino C., Canta A., Nicolini G., Marmiroli P., Cavaletti G. (2005) Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J. Peripher. Nerv. Syst. 10: 202-208. (Pubitemid 40984894)
41. McDonald E.S., Randon K.R., Knight A., Windebank A.J. (2005) Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol. Dis. 18: 305-313. (Pubitemid 40431114)
42. McLeod J.G., Penny R. (1969) Vincristine neuropathy: an electrophysiological and histological study. J. Neurol. Neurosurg. Psychiatry 32: 297-304.
43. Meijer C., de Vries E.G., Marmiroli P., Tredici G., Frattola L., Cavaletti G. (1999) Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy. Neurotoxicology 20: 883-887. (Pubitemid 30091215)
44. Meregalli C., Canta A., Carozzi V.A., Chiorazzi A., Oggioni N., Gilardini A., Ceresa C., Avezza F., Crippa L., Marmiroli P., Cavaletti G. (2009) Bortezomib-induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats. Eur. J. Pain 14:343-350.
45. Nicolini G., Rigolio R., Miloso M., Bertelli A.A., Tredici G. (2001) Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci. Lett. 302: 41-44. (Pubitemid 32244192)
46. Nicolini G., Rigolio R., Scuteri A., Miloso M., Saccomanno D., Cavaletti G., Tredici G. (2003) Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 42: 419-429. (Pubitemid 36044675)
47. O'Connor O.A. (2005) Targeting histones and proteasomes: new strategies for the treatment of lymphoma. J. Clin. Oncol. 23: 6429-6436. (Pubitemid 46218854)
48. Persohn E., Canta A., Schoepfer S., Traebert M., Mueller L., Gilardini A., Galbiati S., Nicolini G., Scuteri A., Lanzani F., Giussani G., Cavaletti G. (2005) Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. Eur. J. Cancer 41: 1460-1466. (Pubitemid 40826471)
49. Pisano C., Pratesi G., Laccabue D., Zunino F., Lo Giudice P., Bellucci A., Pacifici L., Camerini B., Vesci L., Castorina M., Cicuzza S., Tredici G., Marmiroli P., Nicolini G., Galbiati S., Calvani M., Carminati P., Cavaletti G. (2003) Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin. Cancer Res. 9: 5756-5767. (Pubitemid 37499500)
50. Podratz J.L., Rodriguez E.H., Windebank A.J. (2004) Antioxidants are necessary for myelination of dorsal root ganglion neurons, in vitro. Glia 45: 54-58. (Pubitemid 38076227)
51. Poruchynsky M.S., Sackett D.L., Robey R.W., Ward Y., Annunziata C., Fojo T. (2008) Proteasome inhibitors increase tubulin polymerization and stabilization in tissue culture cells: a possible mechanism contributing to peripheral neuropathy and cellular toxicity following proteasome inhibition. Cell Cycle 7: 940-949. (Pubitemid 351573790)
52. Postma T.J., Benard B.A., Huijgens P.C., Ossenkoppele G.J., Heimans J.J. (1993) Longterm effects of vincristine on the peripheral nervous system. J. Neurooncol. 15: 23-27. (Pubitemid 23049695)
53. Quasthoff S., Hartung H.P. (2002) Chemotherapy-induced peripheral neuropathy. J. Neurol. 249: 9-17. (Pubitemid 34119018)
54. Radio N.M., Mundy W.R. (2008) Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29: 361-376.
55. Rigolio R., Miloso M., Nicolini G., Villa D., Scuteri A., Simone M., Tredici G. (2005) Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosis. Neurochem. Int. 46: 205-211.
56. Roytta M., Raine C.S. (1986) Taxol-induced neuropathy: chronic effects of local injection. J Neurocytol. 15: 483-496. (Pubitemid 16045885)
57. Sahenk Z., Brady S.T., Mendell J.R. (1987) Studies on the pathogenesis of vincristine-induced neuropathy. Muscle Nerve 10: 80-84. (Pubitemid 17223315)
58. Schwartz R., Davidson T. (2004) Pharmacology, pharmacokinetics, and practical applications of bortezomib. Oncology (Williston Park) 18: 14-21.
59. Schweitzer V.G. (1993) Ototoxicity of chemotherapeutic agents. Otolaryngol. Clin. North. Am. 26: 759-789. (Pubitemid 23292836)
60. Scuteri A., Galimberti A., Maggioni D., Ravasi M., Pasini S., Nicolini G., Bossi M., Miloso M., Cavaletti G., Tredici G. (2009) Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology 30: 312-319.
61. Shah A., Fischer C., Knapp C.F., Sisken B.F. (2004) Quantitation of neurite growth parameters in explant cultures using a new image processing program. J. Neurosci. Methods 136: 123-131. (Pubitemid 38746622)
62. Siau C., Xiao W., Bennett G.J. (2006) Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp. Neurol. 201: 507-514. (Pubitemid 44344243)
63. Swain S.M., Arezzo J.C. (2008) Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management. Clin. Adv. Hematol. Oncol. 6: 455-467.
64. Ta L.E., Espeset L., Podratz J., Windebank A.J. (2006) Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding. Neurotoxicology 27: 992-1002. (Pubitemid 44838955)
65. Taieb S., Trillet-Lenoir V., Rambaud L., Descos L., Freyer G. (2002) Lhermitte sign and urinary retention: atypical presentation of oxaliplatin neurotoxicity in four patients. Cancer 94: 2434-2340.
66. Thompson S.W., Davis L.E., Kornfeld M., Hilgers R.D., Standefer J.C. (1984) Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54: 1269-1275.
67. Tobinai K. (2007) Proteasome inhibitor, bortezomib, for myeloma and lymphoma. Int. J. Clin. Oncol. 12: 318-326. (Pubitemid 47573415)
68. Tomiwa K., Nolan C., Cavanagh J.B. (1986) The effects of cisplatin on rat spinal ganglia: a study by light and electron microscopy and by morphometry. Acta Neuropathol. (Berlin) 69: 295-308. (Pubitemid 16134891)
69. Tredici G., Cavaletti G., Petruccioli M.G., Fabbrica D., Tedeschi M., Venturino P. (1994) Low-dose glutathione administration in the prevention of cisplatin-induced peripheral neuropathy in rats. Neurotoxicology 15: 701-704. (Pubitemid 24321266)
70. Tredici G., Tredici S., Fabbrica D., Minoia C., Cavaletti G. (1998) Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration. J. Neurooncol. 36: 31-40. (Pubitemid 28230650)
71. Tredici G., Braga M., Nicolini G., et al. (1999) Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats. Exp. Neurol. 159: 551-558. (Pubitemid 29485242)
72. van den Bent M.J., Hilkens P.H., Sillevis Smitt P.A., van Raaij-van den Aarssen V.J., Bontenbal M., Verweij J. (1998) Lhermitte's sign following chemotherapy with docetaxel. Neurology 50: 563-564. (Pubitemid 28119819)
73. Villa D., Miloso M., Nicolini G., Rigolio R., Villa A., Cavaletti G., Tredici G. (2005) Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis. Mol. Cancer Ther. 4: 1439-1447.
74. Wang M.S., Davis A.A., Culver D.G., Wang Q., Powers J.C., Glass J.D. (2004) Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 127: 671-679. (Pubitemid 38295480)
75. Xiao W.H., Zheng F.Y., Bennett G.J., Bordet T., Pruss R.M. (2009) Olesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel. Pain 147: 202-209.